1 – 10 of 433
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
- Inverted erythrocyte membranes demonstrate β2GPI-antiphospholipid antibody interactions and membrane crosslinking
- Fast generation of conditional ROSA26-based mouse models that recapitulate genomic events in human T-ALL
- Targeting BET family proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
- A phase I study in T cell lymphoma patients treated with anti-CD70 simple antibody T ARGX-110
- VANTAGE 095: an international, multicenter, open-label study of vorinostat (MK-0683) in combination with bortezomib in patients with relapsed and refractory multiple myeloma
- Real-world data from 54 Belgian patients from the ponatinib named patient programme (NPP)
- IFM2012-03
- Results from the international, randomized phase 3 study of ibrutinib versus chlorambucil in patients 65 years and older with treatment-naive (TN) CLL/SLL (RESONATE-2 (TM))
- A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL
- A phase I study in T cell lymphoma patients treated with anti-CD70 simple antibody (TM) ARGX-110